Topics

US FDA Office Of New Drugs Reorg: Phase 3 Pushed To January

16:38 EST 3 Dec 2019 | SCRIP

The FDA has confirmed the picks to head most of the new offices in the restructured drug review organization, with...

      

Related Stories

 

Original Article: US FDA Office Of New Drugs Reorg: Phase 3 Pushed To January

NEXT ARTICLE

More From BioPortfolio on "US FDA Office Of New Drugs Reorg: Phase 3 Pushed To January"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...